Evaluation of Antitumor Activity of Rubomycin Deposited in Absorbable Polymeric Microparticles
Overview
Affiliations
An experimental dosage form of rubomycin is developed: the drug is incorporated in absorbable polymeric (polyhydroxybutyrate) matrix in the form of microparticles. Antitumor efficiency of this rubomycin dosage form was studied in laboratory mice with transplanted Ehrlich ascitic carcinoma. Rubomycin deposited in polymeric microparticles exhibited pronounced antitumor activity, inhibited the proliferative activity of Ehrlich ascitic carcinoma, and improved survival of mice with tumors. This dosage form of the drug can be used for local injections.
Murueva A, Shershneva A, Shishatskaya E, Volova T Int J Mol Sci. 2023; 24(19).
PMID: 37834429 PMC: 10573759. DOI: 10.3390/ijms241914983.
Exploring Various Techniques for the Chemical and Biological Synthesis of Polymeric Nanoparticles.
Pulingam T, Foroozandeh P, Chuah J, Sudesh K Nanomaterials (Basel). 2022; 12(3).
PMID: 35159921 PMC: 8839423. DOI: 10.3390/nano12030576.
A Polyhydroxyalkanoates-Based Carrier Platform of Bioactive Substances for Therapeutic Applications.
Zhang X, Liu X, Yang H, Chen J, Lin Y, Han S Front Bioeng Biotechnol. 2022; 9:798724.
PMID: 35071207 PMC: 8767415. DOI: 10.3389/fbioe.2021.798724.
Biomedical Applications of Bacteria-Derived Polymers.
Hinchliffe J, Madappura A, Syed Mohamed S, Roy I Polymers (Basel). 2021; 13(7).
PMID: 33805506 PMC: 8036740. DOI: 10.3390/polym13071081.
Kwiecien I, Radecka I, Kwiecien M, Adamus G Materials (Basel). 2017; 9(5).
PMID: 28773432 PMC: 5503025. DOI: 10.3390/ma9050307.